132 filings
Page 4 of 7
8-K
378eq1yebvf3awed
26 Jun 20
Amendments to Articles of Incorporation or Bylaws
4:16pm
8-K
iizcn9blh
1 Jun 20
Regulation FD Disclosure
6:55am
8-K
wwegig7gssqkztkfs
31 Mar 20
EyeGate Pharma Announces Positive Topline Data in Follow-on Dry Eye Pilot Study
6:55am
8-K
4tnyqrx
24 Mar 20
Departure of Directors or Certain Officers
4:15pm
8-K
d46y 7aua72y
10 Jan 20
Departure of Directors or Certain Officers
4:16pm
8-K
vlwl7m29
3 Jan 20
Departure of Directors or Certain Officers
5:08pm
8-K
4yj59gavfxwoifuz2
31 Dec 19
EyeGate Announces $5.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:05pm
8-K
9ll6 hati2ac7cs19
17 Dec 19
EyeGate Pharma Receives $1.9 Million From Exercised Warrants
8:41am
8-K
askwqfkn
3 Dec 19
Departure of Directors or Certain Officers
6:55am
8-K
j11yrjq17l
2 Dec 19
EyeGate Pharma Announces Additional Positive Top-Line Data in PRK Pivotal Study
6:55am
8-K
684s rb8xl
22 Nov 19
Other Events
6:55am
8-K
9jqivbij2zu45u3
30 Sep 19
EyeGate Enters Into Agreement for $1.9 Million Private Placement
6:55am
8-K
oes322qak77qbvx
23 Sep 19
Other Events
6:57am
8-K
7ww7 77v62q3md2mw6lc
9 Sep 19
Regulation FD Disclosure
6:50am
8-K
ztm lwecrah
29 Aug 19
Material Modifications to Rights of Security Holders
12:45pm
8-K
xdr3p qvz2pba685e
15 Aug 19
Departure of Directors or Certain Officers
6:55am
8-K
vsmgsm
20 Jun 19
Submission of Matters to a Vote of Security Holders
4:15pm
8-K
hvy0l6l
14 May 19
EyeGate Pharma Receives Positive Nasdaq Listing Determination
6:55am
8-K
kjiako3mvt0 5cg3
22 Mar 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
zxpi5r k1
20 Dec 18
Termination of a Material Definitive Agreement
4:30pm